ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for alerts 登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

PRPO Precipio Inc

5.7499
0.00 (0.00%)
プレマーケット
最終更新日: 17:09:35
15分遅延
名称 銘柄コード 市場 種別
Precipio Inc PRPO NASDAQ 普通株式
  前日比 前日比 % 現在値 時刻
0.00 0.00% 5.7499 17:09:35
始値 安値 高値 終値 前日終値
5.7499
この銘柄の詳細情報 »

最新ニュース

日付 時間 ソース タイトル
2024/3/2606:00GLOBEPrecipio Announces Year end 2023 Shareholder Update Call
2024/2/1400:00GLOBEPrecipio to Report $15.2M for FY-2023 (unaudited) Revenues,..
2024/2/0700:00GLOBEPrecipio and Cardinal Health Sign Distribution Agreement for..
2024/1/2400:00GLOBEPrecipio’s Q4-2023 Cash Burn From Operations (unaudited)..
2024/1/2006:05EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
2024/1/1800:30GLOBEPrecipio Signs Distribution Agreement For IV-Cell® and..
2024/1/0506:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/0506:30EDGAR2Form 3 - Initial statement of beneficial ownership of..
2024/1/0307:01EDGAR2Form 8-K - Current report
2024/1/0223:00GLOBEPrecipio Announces Christina Valauri joins the Board of..
2023/12/1507:00EDGAR2Form 8-K - Current report
2023/12/1506:30GLOBEPrecipio Management Shares Thoughts on 2023, and Looks Ahead..
2023/11/1707:15EDGAR2Form 8-K - Current report
2023/11/1707:00GLOBEPrecipio Announces Q3-2023 Shareholder Update Call
2023/11/1406:03EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/0105:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/10/2705:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/10/2705:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/10/2705:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/10/1822:00GLOBEPrecipio to Report $4.5M Q3-2023 Revenues, Double From..
2023/10/0705:34EDGAR2Form 8-K - Current report
2023/10/0323:00GLOBEPrecipio’s Q3 Cash Burn From Operations (unaudited) Declines..
2023/9/2822:00GLOBEPrecipio Continues to Sign New HemeScreen™ Customers
2023/9/2600:00GLOBEPrecipio Reduces Product Revenue Result Needed for Cash Flow..
2023/9/2206:10EDGAR2Form 8-K - Current report
2023/9/1505:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/9/1505:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/9/1505:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/9/1505:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/9/1505:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/9/1505:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/9/1322:30GLOBEPrecipio’s Pathology Division Exceeds Breakeven Revenues in..
2023/8/1505:00EDGAR2Form 8-K - Current report
2023/8/1205:31EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/8/1106:00GLOBEPrecipio Announces Q2-2023 Shareholder Update Call
2023/8/0822:00GLOBEPrecipio Launches Its Much-Anticipated Quantitative BCR-ABL..
2023/8/0322:00GLOBEPrecipio’s Operational Efficiency Measures Continue To..
2023/8/0122:00GLOBEPrecipio Unaudited Q2-2023 Revenues Show combined increase..
2023/7/0805:30EDGAR2Form S-1 - General form for registration of securities under..
2023/6/1422:49GLOBEPrecipio’s Omnia™ Methodology Enables Diagnosis of MDS With..
2023/6/1322:00GLOBEPrecipio Enters into Collaboration with Prestigious New..
2023/6/0821:30GLOBEPrecipio, Inc. Announces Pricing of $2 Million Registered..
2023/6/0722:30GLOBEProjected cash burn reduced by $1.5 million annually from..
2023/5/2300:00GLOBEPrecipio’s Lab Detects BCR-ABL1 Oncogene Co-Expression of..
2023/5/1805:00GLOBEPrecipio Shares Growth Catalysts For HemeScreen
2023/5/1605:00GLOBEPrecipio Announces Q1-2023 Shareholder Update Call
2023/5/0502:00GLOBEPrecipio Adds Substantial Pathology Customer to its..
2023/5/0423:00GLOBEPrecipio Signs Another HemeScreen™ Customer

最近閲覧した銘柄

Delayed Upgrade Clock